Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Be Right and sit tight.

<< Previous

Bullboard Posts

Next >>

Post by askretkaon Jun 21, 2021 2:54pm

285 Views

Post# 33421412

Be Right and sit tight.

That's my take on this stock. I'm not going to try and make any predictions but I want to be on board with my ticket in hand and my luggage on board when the train leaves the station not left behind. Cheers!!!!!

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management